Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 16 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-3.41 Insider Own21.79% Shs Outstand15.06M Perf Week-18.29%
Market Cap364.00M Forward P/E- EPS next Y-4.20 Insider Trans21.88% Shs Float11.78M Perf Month-3.63%
Income-64.47M PEG- EPS next Q-1.18 Inst Own41.70% Short Float3.84% Perf Quarter170.06%
Sales0.00M P/S- EPS this Y21.47% Inst Trans5.02% Short Ratio3.44 Perf Half Y177.12%
Book/sh7.03 P/B3.44 EPS next Y13.51% ROA-89.35% Short Interest0.45M Perf Year66.69%
Cash/sh5.77 P/C4.19 EPS next 5Y- ROE-112.67% 52W Range4.00 - 31.01 Perf YTD206.34%
Dividend Est.- P/FCF- EPS past 5Y- ROI-80.33% 52W High-22.06% Beta2.23
Dividend TTM- Quick Ratio7.19 Sales past 5Y0.00% Gross Margin- 52W Low504.25% ATR (14)2.04
Dividend Ex-Date- Current Ratio7.19 EPS Y/Y TTM39.99% Oper. Margin0.00% RSI (14)42.35 Volatility6.90% 7.21%
Employees45 Debt/Eq0.04 Sales Y/Y TTM- Profit Margin- Recom1.14 Target Price67.50
Option/ShortYes / Yes LT Debt/Eq0.02 EPS Q/Q-316.56% Payout- Rel Volume0.66 Prev Close26.30
Sales Surprise- EPS Surprise6.76% Sales Q/Q- EarningsMar 04 BMO Avg Volume131.37K Price24.17
SMA20-13.76% SMA502.23% SMA20085.11% Trades Volume87,043 Change-8.10%
Date Action Analyst Rating Change Price Target Change
Apr-03-24Initiated Evercore ISI Outperform $65
Mar-28-24Initiated RBC Capital Mkts Outperform $70
Mar-18-24Initiated TD Cowen Outperform
Aug-11-23Initiated CapitalOne Overweight $7
Feb-28-22Initiated Cantor Fitzgerald Overweight $10
Nov-08-21Initiated Credit Suisse Outperform $15
Oct-21-21Initiated William Blair Outperform
Oct-20-21Initiated BMO Capital Markets Outperform $19
Oct-13-21Initiated Oppenheimer Outperform $21
Apr-02-24 04:30PM
Mar-22-24 08:50AM
Mar-21-24 04:30PM
Mar-19-24 08:00AM
Mar-15-24 08:00AM
12:00PM Loading…
Mar-14-24 12:00PM
Mar-06-24 12:53PM
Mar-04-24 07:30AM
Feb-26-24 04:30PM
Feb-23-24 08:00AM
Feb-19-24 08:50AM
Feb-07-24 08:00AM
Feb-06-24 08:59AM
Feb-05-24 08:00AM
08:00AM Loading…
Feb-02-24 08:00AM
Jan-24-24 12:14PM
Jan-05-24 08:30AM
Jan-02-24 08:00AM
Dec-18-23 04:30PM
Dec-10-23 11:00AM
Nov-30-23 08:00AM
Nov-09-23 09:48AM
Nov-08-23 04:30PM
Nov-02-23 09:00AM
Nov-01-23 08:00AM
Oct-09-23 08:30AM
Sep-25-23 08:00AM
08:00AM Loading…
Sep-21-23 08:00AM
Sep-15-23 08:00AM
Aug-11-23 04:05PM
Aug-04-23 04:51PM
Aug-02-23 08:00AM
Jun-22-23 08:00AM
Jun-20-23 08:00AM
Jun-13-23 08:00AM
May-12-23 04:05PM
May-10-23 08:00AM
Apr-13-23 08:00AM
Apr-10-23 04:05PM
Mar-31-23 08:00AM
Mar-23-23 08:00AM
Mar-09-23 08:00AM
Mar-08-23 04:05PM
Feb-17-23 08:20AM
Feb-16-23 04:05PM
Feb-03-23 04:05PM
Jan-30-23 08:00AM
Jan-27-23 01:10PM
Jan-25-23 08:00AM
Jan-24-23 04:25PM
Jan-13-23 08:00AM
Jan-10-23 08:00AM
Jan-04-23 08:00AM
Jan-03-23 08:00AM
Nov-10-22 04:05PM
Sep-26-22 08:00AM
Sep-23-22 08:00AM
Sep-15-22 08:00AM
Aug-12-22 04:05PM
Jun-23-22 04:05PM
Jun-20-22 10:59AM
Jun-07-22 08:00AM
Jun-06-22 08:00AM
May-27-22 08:00AM
May-17-22 08:00AM
May-12-22 04:05PM
Apr-28-22 08:00AM
Apr-26-22 04:05PM
Apr-22-22 08:00AM
Mar-31-22 08:00AM
Mar-25-22 07:30PM
Mar-21-22 08:30AM
Mar-18-22 04:05PM
Mar-10-22 08:00AM
Feb-28-22 08:00AM
Feb-24-22 05:19PM
Feb-02-22 01:38PM
Dec-08-21 11:15AM
Nov-20-21 08:21AM
Nov-12-21 04:05PM
Nov-09-21 08:00AM
Nov-08-21 08:00AM
Oct-15-21 09:39PM
Jasper Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in enabling cures through hematopoietic stem cell therapy. It focuses on the development and commercialization of safer, stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation. The company was founded by Judith Shizuru and Susan Prohaska in March 2018 and is headquartered in Redwood City, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mahal Jeetinder SinghChief Operating OfficerMar 12 '24Option Exercise7.109006,39025,909Mar 12 09:33 PM
Mahal Jeetinder SinghChief Operating OfficerMar 12 '24Sale26.4490023,79225,009Mar 12 09:33 PM
Velan Capital Investment Manag10% OwnerFeb 08 '24Buy12.95350,0004,532,5001,188,500Feb 09 08:40 PM
Carlyle Group Inc.Former 10% OwnerFeb 08 '24Buy12.95190,0002,460,5001,066,189Feb 12 06:23 PM
WIGGANS THOMAS GDirectorNov 28 '23Buy0.6510,0006,48650,000Nov 30 04:05 PM
WIGGANS THOMAS GDirectorNov 21 '23Buy0.6410,0006,38340,000Nov 22 04:06 PM
WIGGANS THOMAS GDirectorNov 20 '23Buy0.6310,0006,30930,000Nov 20 08:14 PM
WIGGANS THOMAS GDirectorNov 17 '23Buy0.6010,0005,96620,000Nov 20 08:14 PM
WIGGANS THOMAS GDirectorNov 16 '23Buy0.6010,0005,96510,000Nov 20 08:14 PM
Lis WilliamDirectorOct 13 '23Sale0.857,9656,77753,521Oct 13 06:56 PM
Mahal Jeetinder SinghSee RemarksJun 13 '23Option Exercise0.719,0006,390296,223Jun 13 08:54 PM
Mahal Jeetinder SinghSee RemarksJun 13 '23Sale1.669,00014,915287,223Jun 13 08:54 PM